BioCardia, Inc.
BCDA
$1.10
-$0.01-0.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.60% | -13.86% | -33.78% | 27.62% | 24.45% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -25.00% | -20.00% | -58.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.71% | -12.36% | 48.33% | -16.67% | -25.77% |
| Change in Net Operating Assets | -197.80% | 146.36% | -109.92% | -308.38% | -77.37% |
| Cash from Operations | -4.58% | 33.56% | -49.34% | -1.39% | -1.92% |
| Capital Expenditure | 100.00% | 50.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 50.00% | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,176.89% | 4,400.00% | -99.93% | 300.18% | 699.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.56% | -12.50% | 88.06% | -5,642.86% | 12.50% |
| Cash from Financing | 4,088.89% | 140.63% | -104.82% | 255.68% | 757.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 304.92% | 44.64% | -164.80% | 13,793.55% | 102.18% |